The DOI matches its Crossref record.
DIFFERENT EFFECTS OF DOPAMINERGIC AND ANTICHOLINERGIC THERAPIES ON COGNITIVE AND MOTOR FUNCTION IN PARKINSON'S DISEASE: A FOLLOW-UP STUDY OF UNTREATED PATIENTS
Abstract
The cognitive performance of a group of 82 newly diagnosed patients with Parkinson's disease who had never been treated was reassessed approximately 4 mths after randomization to one of three monotherapies (levodopa, bromocriptine or anticholinergic drugs). Dopaminergic and anticholinergic treatments both led to improvement in motor control but their effects upon cognitive performance dissociated. Anticholinergic drugs produced impairment in processes underlying the immediate registration of information whilst dopaminergic therapy produced improvement on a task dependent on working memory and cognitive sequencing. Other cognitive measures showed no change on treatment. The deficits that were affected by cholinergic and dopaminergic modulation are those that were most compromised in the early, untreated state in Parkinson's disease. The data support the notion that cognitive impairment in Parkinson's disease is multifactorial in origin: short-term memory processes are served by both dopaminergic and cholinergic subcortico-frontal systems but much of the cognitive impairment of Parkinson's disease is independent of this subcortical neurochemical pathology and may be due to early neuronal dysfunction within the cerebral cortex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Cools, R., & D'Esposito, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.028 · Cited by 1,673
Cools, R. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.024 · Cited by 903
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., & Obeso, J. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70293-5 · Cited by 863
Individual differences in rates of change in cognitive abilities of older persons.
Wilson, R. S., Beckett, L. A., Barnes, L. L., Schneider, J. A., Bach, J., Evans, D. A., & Bennett, D. A. (2002) · Psychology and Aging · doi:10.1037/0882-7974.17.2.179 · Cited by 842
COGNITIVE NEUROSCIENCE OF HUMAN MEMORY
Gabrieli, J. D. E. (1998) · Annual Review of Psychology · doi:10.1146/annurev.psych.49.1.87 · Cited by 808
Waldemar, G., Dubois, B., Emre, M., Georges, J., McKeith, I. G., Rossor, M., Scheltens, P., Tariska, P., & Winblad, B. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01605.x · Cited by 617
Frontal-subcortical circuitry and behavior
Bonelli, R. M., & Cummings, J. L. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.2/rbonelli · Cited by 612
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2013) · Neurodegenerative Diseases · doi:10.1159/000341998 · Cited by 573
The cholinergic system and Parkinson disease
Bohnen, N. I., & Albin, R. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.048 · Cited by 566
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Svenningsson, P., Westman, E., Ballard, C., & Aarsland, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70152-7 · Cited by 499
Executive dysfunction in Parkinson's disease: A review
Dirnberger, G., & Jahanshahi, M. (2013) · Journal of Neuropsychology · doi:10.1111/jnp.12028 · Cited by 486
The impact of deep brain stimulation on executive function in Parkinson's disease
Jahanshahi, M., Ardouin, C. M. A., Brown, R. G., Rothwell, J. C., Obeso, J., Albanese, A., Rodriguez-Oroz, M. C., Moro, E., Benabid, A. L., Pollak, P., et al. (2000) · Brain · doi:10.1093/brain/123.6.1142 · Cited by 425
Zgaljardic, D. J., Borod, J. C., Foldi, N. S., & Mattis, P. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00001 · Cited by 421
Cholinesterase Inhibitors: A New Class of Psychotropic Compounds
Cummings, J. L. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.4 · Cited by 384
Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Constantine, G. M., Mathis, C. A., Davis, J. G., Moore, R. Y., & DeKosky, S. T. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0971-0 · Cited by 364
Spatial and non-spatial working memory at different stages of Parkinson's disease
Owen, A. M., Iddon, J. L., Hodges, J. R., Summers, B. A., & Robbins, T. W. (1997) · Neuropsychologia · doi:10.1016/s0028-3932(96)00101-7 · Cited by 355
Stocco, A., Lebiere, C., & Anderson, J. R. (2010) · Psychological Review · doi:10.1037/a0019077 · Cited by 350
Ferreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D., Deuschl, G., Dietrichs, E., Fabbrini, G., Friedman, A., Kanovsky, P., et al. (2013) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03866.x · Cited by 348
Calabresi, P., Picconi, B., Parnetti, L., & Di Filippo, M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70600-7 · Cited by 338
Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson’s disease
Pillon, B., Ardouin, C., Damier, P., Krack, P., Houeto, J. L., Klinger, H., Bonnet, A. M., Pollak, P., Benabid, A. L., & Agid, Y. (2000) · Neurology · doi:10.1212/wnl.55.3.411 · Cited by 332
D1- Versus D2-Receptor Modulation of Visuospatial Working Memory in Humans
Müller, U., von Cramon, D. Y., & Pollmann, S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02720.1998 · Cited by 325
Lewis, S. J. G., Slabosz, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.10.001 · Cited by 309
Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., Kanovsky, P., Larsen, J. P., Lees, A., Oertel, W., Poewe, W., et al. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01547.x · Cited by 297
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
Treatment interventions for Parkinson's disease: an evidence based assessment
Rascol, O., Goetz, C., Koller, W., Poewe, W., & Sampaio, C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08520-3 · Cited by 279
Sensory and cognitive functions of the basal ganglia
Brown, L. L., Schneider, J. S., & Lidsky, T. I. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80003-7 · Cited by 278
Cognitive dysfunction and dementia in Parkinson?s disease
Bosboom, J. L. W., Stoffers, D., & Wolters, E. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0168-1 · Cited by 273
McDowell, S. (1998) · Brain · doi:10.1093/brain/121.6.1155 · Cited by 270
Cognitive impairment and dementia in Parkinson's disease
Pagonabarraga, J., & Kulisevsky, J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.029 · Cited by 257
Barch, D. M., & Carter, C. S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.019 · Cited by 222
Current treatment options for Alzheimer’s disease and Parkinson’s disease dementia
Y.Y. Szeto, J., & J.G. Lewis, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151208112754 · Cited by 198
A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism
Moustafa, A. A., Sherman, S. J., & Frank, M. J. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.07.011 · Cited by 192
Mentis, M. J., McIntosh, A. R., Perrine, K., Dhawan, V., Berlin, B., Feigin, A., Edwards, C., Mattis, P., & Eidelberg, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.746 · Cited by 136
The contribution of the study of neurodegenerative disorders to the understanding of human memory
Panegyres, P. K. (2004) · QJM · doi:10.1093/qjmed/hch096 · Cited by 60
Differential dopaminergic modulation of executive control in healthy subjects
Roesch-Ely, D., Scheffel, H., Weiland, S., Schwaninger, M., Hundemer, H.-P., Kolter, T., & Weisbrod, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2027-z · Cited by 56
Metadata
- Authors
- COOPER, J. A., SAGAR, H. J., DOHERTY, S. M., JORDAN, N., TIDSWELL, P., & SULLIVAN, E. V.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1992
- Volume
- 115
- Issue
- 6
- Pages
- 1701-1725
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1988986349
- Cited by
- 275
- References
- 0
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.